JAK2(V617F) allele burden ⩾50% is associated with response to ruxolitinib in persons with MPN-associated myelofibrosis and splenomegaly requiring therapy.
| Image |  |
|---|---|
| Description | scientific article published on 29 February 2016 |
| Author/s |
author: Catherine Klersy Margherita Massa Laura Villani Elisa Bonetti Rita Campanelli Vittorio Rosti Paolo Catarsi |
| Publication date | February 29, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |